Fly News Breaks for March 3, 2015
DGX
Mar 3, 2015 | 07:51 EDT
As previously reported, Canaccord upgraded Quest Diagnostics to Buy from Hold citing expectations for an acceleration in primary office visits and lab testing above historical levels, M&A opportunities, and share repurchases. Canaccord raised its price target to $82 from $63 on Quest Diagnostics shares.
News For DGX From the Last 2 Days
There are no results for your query DGX